ATE214050T1 - Piperidin-derivate - Google Patents

Piperidin-derivate

Info

Publication number
ATE214050T1
ATE214050T1 AT96106213T AT96106213T ATE214050T1 AT E214050 T1 ATE214050 T1 AT E214050T1 AT 96106213 T AT96106213 T AT 96106213T AT 96106213 T AT96106213 T AT 96106213T AT E214050 T1 ATE214050 T1 AT E214050T1
Authority
AT
Austria
Prior art keywords
agents
carbonyl group
allergies
coor
salts
Prior art date
Application number
AT96106213T
Other languages
English (en)
Inventor
Henk Timmerman
Zhang Mingqiang
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Application granted granted Critical
Publication of ATE214050T1 publication Critical patent/ATE214050T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT96106213T 1995-04-24 1996-04-19 Piperidin-derivate ATE214050T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP09879795A JP3779349B2 (ja) 1995-04-24 1995-04-24 ピペリジン誘導体

Publications (1)

Publication Number Publication Date
ATE214050T1 true ATE214050T1 (de) 2002-03-15

Family

ID=14229354

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96106213T ATE214050T1 (de) 1995-04-24 1996-04-19 Piperidin-derivate

Country Status (7)

Country Link
US (1) US5714501A (de)
EP (1) EP0739881B1 (de)
JP (1) JP3779349B2 (de)
KR (1) KR100368949B1 (de)
AT (1) ATE214050T1 (de)
DE (1) DE69619577T2 (de)
ES (1) ES2173993T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7211582B1 (en) 1994-12-30 2007-05-01 Sepracor Inc. Methods for treating urticaria using descarboethoxyloratadine
US7214683B1 (en) 1994-12-30 2007-05-08 Sepracor Inc. Compositions of descarboethoxyloratadine
US6248308B1 (en) 1998-04-14 2001-06-19 Sepracor Inc. Methods of using norastemizole in combination with leukotriene inhibitors to treat or prevent asthma
WO2003018538A1 (en) 2001-08-31 2003-03-06 Ajinomoto Co., Inc. Novel diarylalkene derivatives and novel diarylalkane derivatives
US7189757B2 (en) * 2001-10-16 2007-03-13 Hypnion, Inc. Treatment of sleep disorders using CNS target modulators

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356184A (en) * 1980-06-04 1982-10-26 G. D. Searle & Co. Anti-allergic or antihypertensive 1-piperidinylmethyl benzenamines
US4282233B1 (en) * 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
US5231105A (en) * 1987-06-02 1993-07-27 Ajinomoto Co., Inc. Ethylamine derivatives and antihypertensives containing the same
FR2620121B1 (fr) * 1987-09-09 1990-01-05 Synthelabo ((pyrimidinyl-2)-aminoalkyl)-1 piperidines, leur preparation et leur application en therapeutique
US4863931A (en) * 1988-09-15 1989-09-05 Schering Corporation Antihistaminic fluoro substituted benzocycloheptapyridines
CA2015949A1 (en) * 1989-05-22 1990-11-22 Yasuo Ito Piperidine derivative, method for preparation thereof, and a pharmaceutical composition comprising the same
US5508280A (en) * 1990-05-18 1996-04-16 Merrell Pharmaceuticals, Inc. 5H-Dibenzo (A,D) cycloheptenes as muscarinic receptor antagonists
JP2624372B2 (ja) * 1990-11-15 1997-06-25 宇部興産株式会社 ジアリールメトキシピペリジン誘導体
JPH05239002A (ja) * 1992-02-27 1993-09-17 Hokuriku Seiyaku Co Ltd 三環系化合物
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
JPH06116273A (ja) * 1992-10-08 1994-04-26 Hokuriku Seiyaku Co Ltd 三環系化合物
AU674569B2 (en) * 1993-02-16 1997-01-02 Ube Industries, Ltd. Quinoline derivative
JP3193508B2 (ja) * 1993-03-05 2001-07-30 興和株式会社 ピペリジン誘導体
JP3338913B2 (ja) * 1993-06-29 2002-10-28 大鵬薬品工業株式会社 テトラゾール誘導体
US5464840A (en) * 1993-12-06 1995-11-07 Schering Corporation Tricyclic derivatives, compositions and methods of use
KR100351012B1 (ko) * 1994-04-20 2002-12-26 아지노모토 가부시키가이샤 피페리딘유도체및이를함유하는항혈소판제

Also Published As

Publication number Publication date
EP0739881A3 (de) 1999-02-03
JPH08291142A (ja) 1996-11-05
KR100368949B1 (ko) 2003-05-16
EP0739881B1 (de) 2002-03-06
EP0739881A2 (de) 1996-10-30
US5714501A (en) 1998-02-03
DE69619577D1 (de) 2002-04-11
DE69619577T2 (de) 2002-07-18
JP3779349B2 (ja) 2006-05-24
KR960037657A (ko) 1996-11-19
ES2173993T3 (es) 2002-11-01

Similar Documents

Publication Publication Date Title
SE0104332D0 (sv) Therapeutic agents
ATE194335T1 (de) 4,5-diaryloxazol-derivate
WO2003059269A3 (en) Acridone inhibitors of impdh enzyme
ATE180780T1 (de) 2-(piperidin-4-yl, pyridin-4-yl und tetrahydropyridin-4-yl)-benzofuran-7-carbamat derivate, ihre herstellung und verwendung als acetylcholinesterase inhibitoren
ATE252074T1 (de) Phenylalkylcarbonsäure-derivate
ATE214050T1 (de) Piperidin-derivate
MY121580A (en) 1-(1,2-disubstituted piperidinyl)-4-(benzimidazolyl-and imidazopyridinyl)- piperidine derivatives
KR930702355A (ko) 피롤로아제핀 화합물
EP0753511A4 (de) Indol-derivate und diese enthaltende arzneimittel
DK1256581T3 (da) Forebyggende eller terapeutiske midler til gastrisk eller ösofageal regurgitation
ATE257479T1 (de) 5-ring heteroarylsubstituierte 1,4- dihydropyridine als bradykinin antagonisten
DE69805033D1 (de) Tetrazolderivate als LTD4 und H1 Antagonisten
DK0556813T3 (da) Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler
NO904135D0 (no) Fremgangsmaate for fremstilling av nye alkylpiperidiner.
GR3022450T3 (en) Piperidine derivatives with antihistaminic and antileukohienic activity.
DE69526595D1 (de) Pyridoncarbonsäurederivate substituiert von bicyclischer aminogruppe, deren ester und salze, und bicyclisches amin als zwischenprodukt davon
HU9602534D0 (en) Use of biphenyl methyl imidazole derivatives for producing pharmaceutical compositions having ocular tension derpessant activity
PL1603877T3 (pl) Nowe pochodne aminopirydyny jako antagoniści mGluR5
GB9402016D0 (en) Therapeutic agents
WO1996017843A3 (en) Novel pyrimidinyloxy- and pyrimidinylamino-ethylphenyl-dioxolane derivatives
EP0573659A4 (en) Pyrazolothiazolopyrimidine derivative
DK0810223T3 (da) Adamantylsubstituerede oxindoler som farmaceutiske midler
ATE262522T1 (de) Benzimidazolverbindungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties